<DOC>
	<DOCNO>NCT00003980</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I trial study effectiveness BIBX 1382 treat patient solid tumor .</brief_summary>
	<brief_title>BIBX 1382 Treating Patients With Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose oral BIBX 1382 patient solid tumor . II . Determine qualitative quantitative toxicity oral BIBX 1382 patient . III . Determine predictability , duration , intensity , onset , reversibility , dose relationship toxicity oral BIBX 1382 patient . IV . Determine safe optimal dos oral BIBX 1382 Phase II study . V. Assess pharmacokinetics oral BIBX 1382 patient . VI . Document antitumor activity patient treat oral BIBX 1382 . OUTLINE : This dose escalation study . Patients receive BIBX 1382 IV 1 hour follow 7 day later oral BIBX 1382 . Beginning 3 day later , patient receive oral BIBX 1382 daily 28 day . Courses daily oral BIBX 1382 repeat every 28 day absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos oral BIBX 1382 . The maximum tolerated dose ( MTD ) define dose dose limit toxicity occur least 2 6 patient . Patients follow 4 week . PROJECTED ACCRUAL : A total 40-80 patient accrue study 18 month .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven solid tumor amenable standard treatment No symptomatic brain involvement leptomeningeal disease PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 02 Life expectancy : At least 3 month Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL Other liver function test great 2 time upper limit normal ( unless relate liver metastasis ) Renal : Creatinine great 1.4 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 3 month study No active bacterial infection No nonmalignant disease would incompatible study No prior alcoholism , drug addiction , psychotic disorder PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy Chemotherapy : At least 4 week since prior chemotherapy ( 6 week nitrosoureas ) Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy ( 6 week extensive radiotherapy ) No concurrent radiotherapy Surgery : Not specify Other : No concurrent investigational antitumor drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>